Roberto N Miranda

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. doi request reprint Anaplastic large cell lymphoma involving the breast: a clinicopathologic study of 6 cases and review of the literature
    Roberto N Miranda
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Arch Pathol Lab Med 133:1383-90. 2009
  2. pmc MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
    Shimin Hu
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Blood 121:4021-31; quiz 4250. 2013
  3. doi request reprint High-grade B cell lymphoma, unclassifiable, with blastoid features: an unusual morphological subgroup associated frequently with BCL2 and/or MYC gene rearrangements and a poor prognosis
    Rashmi Kanagal-Shamanna
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Histopathology 61:945-54. 2012
  4. doi request reprint Extranodal NK/T-cell lymphoma, nasal type, arising in association with saline breast implant: expanding the spectrum of breast implant-associated lymphomas
    Tariq N Aladily
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 36:1729-34. 2012
  5. doi request reprint Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases
    Eric Y Loo
    Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 37:1290-7. 2013
  6. pmc CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
    Shimin Hu
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    Blood 121:2715-24. 2013
  7. doi request reprint Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation
    Daniela Hoehn
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Hum Pathol 43:1828-38. 2012
  8. doi request reprint CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases
    Jesse Jaso
    Department of Pathology, The University of Texas Medical School at Houston, Houston, TX 77030, USA
    Hum Pathol 43:1436-43. 2012
  9. doi request reprint Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q)
    Rashmi Kanagal-Shamanna
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Cancer Genet 206:42-6. 2013
  10. doi request reprint B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome
    Shaoying Li
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Mod Pathol 25:145-56. 2012

Collaborators

Detail Information

Publications23

  1. doi request reprint Anaplastic large cell lymphoma involving the breast: a clinicopathologic study of 6 cases and review of the literature
    Roberto N Miranda
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Arch Pathol Lab Med 133:1383-90. 2009
    ..Lymphomas involving the breast are rare, and most cases are of B-cell lineage; T-cell neoplasms represent less than 10% of all breast lymphomas...
  2. pmc MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
    Shimin Hu
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Blood 121:4021-31; quiz 4250. 2013
    ..In conclusion, the data suggest that MYC/BCL2 coexpression, rather than cell-of-origin classification, is a better predictor of prognosis in patients with DLBCL treated with R-CHOP...
  3. doi request reprint High-grade B cell lymphoma, unclassifiable, with blastoid features: an unusual morphological subgroup associated frequently with BCL2 and/or MYC gene rearrangements and a poor prognosis
    Rashmi Kanagal-Shamanna
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Histopathology 61:945-54. 2012
    ..At a haematopathology workshop, experts had suggested the term 'high-grade B cell lymphoma, unclassifiable, with blastoid features', and recommended further studies...
  4. doi request reprint Extranodal NK/T-cell lymphoma, nasal type, arising in association with saline breast implant: expanding the spectrum of breast implant-associated lymphomas
    Tariq N Aladily
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 36:1729-34. 2012
    ..In addition, we believe this case is important to report, because it expands the spectrum of T-cell lymphomas that can be associated with breast implants and may be a forerunner of additional cases to follow...
  5. doi request reprint Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases
    Eric Y Loo
    Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 37:1290-7. 2013
    ..We conclude that iatrogenic immunodeficiency-associated CHL is highly associated with Epstein-Barr virus infection, and patients usually have a good outcome after discontinuation of immunomodulatory agents and chemotherapy for CHL. ..
  6. pmc CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
    Shimin Hu
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    Blood 121:2715-24. 2013
    ....
  7. doi request reprint Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation
    Daniela Hoehn
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Hum Pathol 43:1828-38. 2012
    ..We conclude that splenic B-cell lymphoma of various types can undergo prolymphocytoid transformation with more than 55% prolymphocytes in the blood mimicking B-cell prolymphocytic leukemia...
  8. doi request reprint CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases
    Jesse Jaso
    Department of Pathology, The University of Texas Medical School at Houston, Houston, TX 77030, USA
    Hum Pathol 43:1436-43. 2012
    ..Our results show that CD5 expression is rare in MALT lymphoma, and is often associated with nongastric disease and an increased tendency to present with disseminated disease. Overall survival is excellent with appropriate therapy...
  9. doi request reprint Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q)
    Rashmi Kanagal-Shamanna
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Cancer Genet 206:42-6. 2013
    ..The median overall survival was 64 months. In all cases, del(20q) was present at the time of diagnosis...
  10. doi request reprint B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome
    Shaoying Li
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Mod Pathol 25:145-56. 2012
    ..Tumors with extra MYC signals plus IGH@BCL2 or MYC rearrangement plus extra BCL2 signals, respectively, appear to behave as poorly as MYC/BCL2 lymphomas, possibly expanding the disease spectrum...
  11. doi request reprint Myelodysplastic syndromes with deletions of chromosome 11q lack cryptic MLL rearrangement and exhibit characteristic clinicopathologic features
    Sa A Wang
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Leuk Res 35:351-7. 2011
    ..These clinicopathological features are likely attributed to commonly deleted regions of 11q and their involved genes...
  12. doi request reprint Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components
    Sa A Wang
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Am J Hematol 88:219-24. 2013
    ..The presentation, treatment, and outcome of patients with SM-AHNMD is often dictated by the type of AHNMD...
  13. doi request reprint Expression of serine 194-phosphorylated Fas-associated death domain protein correlates with proliferation in B-cell non-Hodgkin lymphomas
    Elias Drakos
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Hum Pathol 42:1117-24. 2011
    ..9, P < .0001). These data provide evidence that serine 194 phosphorylated Fas-associated death domain protein is involved in the proliferation of normal and neoplastic B cells and has features of a novel proliferation marker...
  14. doi request reprint Phenotypic evolution in a case of peripheral T-cell lymphoma suggests the presence of tumor heterogeneity
    Alyaa Al-Ibraheemi
    Department of Pathology and Laboratory Medicine, The University of Texas Medical School at Houston, Houston, TX, USA
    J Cutan Pathol 40:573-9. 2013
    ..These results highlight the utility of sequential immunophenotypic and molecular analysis of PTCL cases at the time of relapse to better understand the mechanisms of disease...
  15. pmc Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma
    Qingshan Yang
    Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA
    Blood 120:3491-500. 2012
    ..Genetic knockdown of Pim-1/Pim-2 affected similar proteins in MCL cell lines. Collectively these data demonstrate Pim kinases as therapeutic targets in MCL...
  16. doi request reprint Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases
    Tariq N Aladily
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 36:1000-8. 2012
    ..In contrast, patients who present with a distinct mass may have advanced stage or possibly systemic disease and have a poorer prognosis...
  17. pmc Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study
    Sylvia Hoeller
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 1439, USA
    Hum Pathol 44:110-21. 2013
    ..The lack of a clonal relationship between the MCL and CLL/SLL components suggests that MCL and CLL/SLL components represent distinct disease processes and do not share a common progenitor B-cell...
  18. doi request reprint Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification
    Wei Liu
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    Mod Pathol 24:375-83. 2011
    ..These new assigned categories fail to capture the distinct features of PEL, where the phenotype of PEL correlates with a very complex karyotype and an extremely aggressive clinical course...
  19. doi request reprint T-cell large granular lymphocyte leukemia associated with myelodysplastic syndrome: a clinicopathologic study of nine cases
    Yang O Huh
    Department of Hematopathology, Unit 72, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Am J Clin Pathol 131:347-56. 2009
    ..The median hemoglobin level and absolute lymphocyte count were lower in patients with T-LGL/MDS (P < .05). The frequency of coexistent T-LGL and MDS at our institution suggests an etiologic relationship rather than simple coincidence...
  20. doi request reprint Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms
    Sameer S Talwalkar
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 32:1299-309. 2008
    ..003). In the disseminated group, patients with DLBCL had a worse disease-free survival compared with patients with mucosa-associated lymphoid tissue lymphoma or follicular lymphoma (P=0.01)...
  21. pmc Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study
    Carlo Visco
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Haematologica 98:255-63. 2013
    ..BCL2 translocated germinal center subtype patients have worse prognosis after rituximab-CHOP, irrespective of MYC status, but the presence of combined gene breaks significantly overcomes the prognostic relevance of isolated lesions...
  22. doi request reprint 8p11 myeloproliferative syndrome: a review
    Courtney C Jackson
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Hum Pathol 41:461-76. 2010
    ..The most common partner is ZNF198 on chromosome 13q12. In the current World Health Organization classification, the 8p11 myeloproliferative syndrome is designated as "myeloid and lymphoid neoplasms with FGFR1 abnormalities."..
  23. doi request reprint HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis
    Mei Liang
    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Mod Pathol 23:381-91. 2010
    ..Inhibition of HDM4 may serve as a potential approach in the design of therapy for patients with mantle cell lymphoma...